Total Equity - Daewoong Pharma (KRX:069620) - Alpha Spread

Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 138 700 KRW -0.93% Market Closed
Market Cap: 1.6T KRW
Have any thoughts about
Daewoong Pharma?
Write Note

Daewoong Pharma
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Daewoong Pharma
Total Equity Peer Comparison

Comparables:
000100
326030
128940
S
000250
C
068760

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Daewoong Pharma
KRX:069620
Total Equity
â‚©767.3B
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
5%
Yuhan Corp
KRX:000100
Total Equity
â‚©2.1T
CAGR 3-Years
3%
CAGR 5-Years
5%
CAGR 10-Years
5%
SK Biopharmaceuticals Co Ltd
KRX:326030
Total Equity
â‚©283.7B
CAGR 3-Years
-9%
CAGR 5-Years
37%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Total Equity
â‚©1.1T
CAGR 3-Years
12%
CAGR 5-Years
8%
CAGR 10-Years
7%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Total Equity
â‚©276.5B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
11%
C
Celltrion Pharm Inc
KOSDAQ:068760
Total Equity
â‚©381B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
8%

See Also

What is Daewoong Pharma's Total Equity?
Total Equity
767.3B KRW

Based on the financial report for Jun 30, 2024, Daewoong Pharma's Total Equity amounts to 767.3B KRW.

What is Daewoong Pharma's Total Equity growth rate?
Total Equity CAGR 10Y
5%

Over the last year, the Total Equity growth was 12%. The average annual Total Equity growth rates for Daewoong Pharma have been 12% over the past three years , 8% over the past five years , and 5% over the past ten years .

Back to Top